Sterilization of HIV with irradiation: relevance to infected bone allografts.

BACKGROUND Bone allograft banks commonly sterilize frozen bone by irradiation. The dose-response relationship for HIV is calculated and the dose required to inactivate the bioburden of virus that may be present in allograft bone is determined. METHODS A virus titre experiment is performed using irradiated frozen HIV. The virus is maintained on dry ice (approximately -70 degrees C) and is exposed to a cobalt 60 source with 0-40 kGy irradiation at 5 kGy intervals. Lymphocyte cell cultures are exposed to serial dilutions of the irradiated virus. The virus titre is quantified by cytological changes of HIV infection and p24 immunofluorescence. RESULTS There is a linear relationship between the virus titre and the radiation dose delivered. The inactivation rate of irradiated virus was 0.1134 log10 tissue culture infective doses 50/mL per kGy (95% confidence intervals, 0.1248-0.1020). The irradiation dose required to inactivate the HIV bioburden in allograft bone is 35 kGy. The irradiation dose required to achieve a sterility assurance level of 10(-6) is 89 kGy. This dose exceeds current recommendations for sterilizing medical products and the current practice of many bone banks. CONCLUSIONS It is concluded that gamma irradiation should be disregarded as a significant virus inactivation method for bone allografts.

[1]  J. Sodroski,et al.  Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity , 1986, Nature.

[2]  H. Duc-Nguyen Enhancing effect of diethylaminoethyl-dextran on the focus-forming titer of a murine sarcoma virus (Harvey strain) , 1968, Journal of virology.

[3]  A. Rein,et al.  Abrogation of Fv-1b restriction with murine leukemia viruses inactivated by heat or by gamma irradiation , 1978, Journal of virology.

[4]  K. Steimer,et al.  Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein , 1986, Nature.

[5]  S. Wain-Hobson,et al.  Relationship of AIDS to other retroviruses , 1985, Nature.

[6]  L. Dahners,et al.  Chemical sterilization of bacterially contaminated bone without destruction of osteogenic potential. , 1989, Journal of orthopaedic trauma.

[7]  R. Schooley,et al.  Radiosensitivity of HIV-1--potential application to sterilization of bone allografts. , 1991, AIDS.

[8]  Mark L. Pearson,et al.  Complete nucleotide sequence of the AIDS virus, HTLV-III , 1985, Nature.

[9]  A. Zuckerman,et al.  Effect of Gamma Irradiation on the Human Immunodeficiency Virus and Human Coagulation Proteins , 1989, Vox sanguinis.

[10]  J. Chermann,et al.  INACTIVATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS BY HEAT, GAMMA RAYS, AND ULTRAVIOLET LIGHT , 1985, The Lancet.

[11]  D. Ho,et al.  Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. , 1991, The New England journal of medicine.

[12]  J. Lifson,et al.  AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. , 1986, Science.

[13]  R. Montelaro,et al.  A formalin-inactivated whole SIV vaccine confers protection in macaques. , 1989, Science.

[14]  M. Tersmette,et al.  Inactivation of human immunodeficiency virus by gamma radiation and its effect on plasma and coagulation factors , 1991, Transfusion.

[15]  C. Burrell,et al.  Synthesis of human immunodeficiency virus DNA in a cell-to-cell transmission model. , 1992, AIDS research and human retroviruses.

[16]  D. Francis,et al.  Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV). , 1985, Journal of immunological methods.

[17]  R. Schooley,et al.  Inactivation of Human Immunodeficiency Virus by Betadine , 1987, Infection Control.

[18]  Martin-Martin Ls,et al.  Disinfection and inactivation of the human T lymphotropic virus type III/Lymphadenopathy-associated virus. , 1985 .

[19]  A. Rainbow,et al.  DNA strand breakage and biological functions of human adenovirus after gamma irradiation. , 1972, Radiation research.

[20]  J. Levy,et al.  AIDS-associated retroviruses (ARV) can productively infect other cells besides human T helper cells. , 1985, Virology.

[21]  S. Sattar,et al.  Survival and disinfectant inactivation of the human immunodeficiency virus: a critical review. , 1991, Reviews of infectious diseases.

[22]  L. Resnick,et al.  Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. , 1986, JAMA.

[23]  S. Rasheed,et al.  Effects of gamma irradiation on the human immunodeficiency virus. A study in frozen human bone-patellar ligament-bone grafts obtained from infected cadavera. , 1994, The Journal of bone and joint surgery. American volume.

[24]  Unusual resistance to ionizing radiation of the viruses of kuru, Creutzfeldt-Jakob disease, and scrapie. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Oakeshott,et al.  Human Immunodeficiency Virus Infection of Human Bone Derived Cells , 1996, Clinical orthopaedics and related research.

[26]  S. Silver,et al.  Cation Fluxes and Permeability Changes Accompanying Bacteriophage Infection of Escherichia coli , 1968, Journal of virology.